ReviewACS pharmacology & translational science2021

Pyruvate Dehydrogenase as a Therapeutic Target for Nonalcoholic Fatty Liver Disease.

Christina T Saed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.